Patient
This 17-year-old male athlete underwent cardiovascular evaluation in our Institute for the first time in 1995, selected as member of the national swimming team, based on his excellent athletic results. In the personal history no cardiac symptoms or previous cardiovascular diseases were reported. The family history was negative for known cardiovascular diseases and sudden cardiac death in close relatives.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pelliccia A, Fagard R, Bjornstad HH, Anastassakis A, Arbustini E, Assanelli D, Biffi A, Borjesson M, Carre F, Corrado D, Delise P, Dorwarth U, Hirth A, Heidbuchel H, Hoffmann E, Melwig KP, Panhuyzen-Goedkoop NM, Pisani A, Solberg EE, Vanbuuuren F, Vanhees L. Recommendations for competitive sports participation in athletes with cardiovascular disease. Eur Heart J 2005, 26:1422−1445
Maron BJ, Zipes Douglas P. 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities. JACC 2005, 45(8):1318−1321.
Panza JA, Maron BJ. Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood. Am J Cardiol 1989, 63:1258−1265
Montgomery JV, Harris KM, Casey SA, Zenovich AG, Maron BJ. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol 2005, 96:270−275
Pelliccia A, Di Paolo FM, Quattrini FM, et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med Jan 10 2008, 358(2):152−161
Pelliccia A, Maron A, Maron J, et al. The upper limits of physiological cardiac hypertrophy in highly trained elite athletes. N Engl J Med Jan 31 1991, 324(5):295−301
Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports including sudden death. Circulation 2006, 114:1633−1644
Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005, 112:855−861
Maron BJ, Niimura H, Casey SA, Soper MK, Wright GB, Seidman JG, Seidman CE. Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol 2001, 38:315−321
Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003, 107(17):2171−2174
Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sport activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003, 42:1959−1963
British Broadcasting Cooperation. Midfielder Marc-Vivien Foe dies after collapsing during an international in France. news.bbc.co.uk/sport1/hi/football/3024360.stm
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag London Limited
About this chapter
Cite this chapter
Giacinto, B.D., Paolo, F.M.D., Pelliccia, A. (2009). An Elite Athlete with Controversial Left Ventricular Hypertrophy. In: Pelliccia, A. (eds) Sports Cardiology Casebook. Springer, London. https://doi.org/10.1007/978-1-84882-042-5_26
Download citation
DOI: https://doi.org/10.1007/978-1-84882-042-5_26
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-041-8
Online ISBN: 978-1-84882-042-5
eBook Packages: MedicineMedicine (R0)